Hansoh Pharma (3692.HK) Financial Analysis & Valuation | Quarter Chart
Hansoh Pharma (3692.HK)
3692.HKPrice: $3.78
Fair Value: 🔒
🔒score
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including central nervous system diseases, o... more
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research,... more
Description
Shares
| Market Cap | $22.90B | Exchange | HKSE |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | CN | CEO | Hui Juan Zhong |
| IPO Date | 2019-06-14 | CAGR | 0.12% |
| Employees | 9,347 | Website | www.hspharm.com |
| Div. Yield | 2.58% | Payout Ratio | 0.36% |
| Buy Back Yield | 0.02% | Total Yield | 2.6% |
3692.HK chart loading...
Fundamentals
Technicals
| Enterprise Value | $187.87B | P/E Ratio | 28.9 |
| Forward P/E | 27.91 | PEG Ratio | 0.62 |
| P/S Ratio | 4.96 | P/B Ratio | 2.09 |
| P/CF Ratio | 18.73 | P/FCF Ratio | 19.83 |
| EPS | $0.13 | EPS Growth 1Y | 68.69% |
| EPS Growth 3Y | 96.47% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 40.04% | Gross Margin | 0.9% |
| Operating Margin | 0.36% | Profit Margin | 0.37% |
| ROE | 0.17% | ROA | 0.14% |
| ROCE | 0.15% | Current Ratio | 8.09 |
| Quick Ratio | 7.95 | Cash Ratio | 0.78 |
| Debt/Equity | 0 | Interest Coverage | 3602.02 |
| Altman Z Score | 25.34 | Piotroski Score | 7 |